Brief: Bio-Rad Q1 Sales USD 592.1 Million
30/04/2026 21:15
Apr 30 (Reuters) - Bio-Rad Q1 EPS USD -19.55. Q1 gross margin 52.3% Q1 net income USD -527.1 million outlook FY adjusted revenue growth -3%
Recent news on Bio-Rad Laboratories
See all newsUS RESEARCH ROUNDUP-Cencora, Dave, Uber
Bio-Rad Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Bio-Rad's Q3 revenue comes slightly above estimates on Clinical Diagnostics growth
Brief: Bio-Rad Q3 EBIT Margin -7.6%
Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary